Global Influenza A Virus, H3N2 Subtype Infections Drug Market 2021 by Manufacturers, Regions, Type and Application, Forecast to 2026

  • receipt Report ID : 83229
  • calendar_today Published On: Apr, 2021
  • file_copy Pages: 156
  • list Pharmaceuticals and Healthcare
Buy @ $3500

The Influenza A Virus, H3N2 Subtype Infections Drug market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations, recent developments, opportunities analysis, strategic market growth analysis, product launches, area marketplace expanding, and technological innovations.

According to our latest research, the global Influenza A Virus, H3N2 Subtype Infections Drug size is estimated to be xx million in 2021 from USD xx million in 2020, with a change of XX% between 2020 and 2021. The global Influenza A Virus, H3N2 Subtype Infections Drug market size is expected to grow at a CAGR of xx% for the next five years.

Market segmentation

Influenza A Virus, H3N2 Subtype Infections Drug market is split by Type and by Application. For the period 2016-2026, the growth among segments provide accurate calculations and forecasts for sales by Type and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.

Market segment by Type, covers

NEO-8877

NP-025

NSC-61610

NVINF-1

Others

Market segment by Application can be divided into

Clinic

Hospital

Others

The key market players for global Influenza A Virus, H3N2 Subtype Infections Drug market are listed below:

AbbVie Inc

AIMM Therapeutics B.V.

Aphios Corporation

Celltrion, Inc.

FluGen, Inc.

Glide Pharmaceutical Technologies Limited

ILiAD Biotechnologies, LLC

Inovio Pharmaceuticals, Inc.

Johnson & Johnson

Medicago Inc.

MedImmune, LLC

Mucosis B.V.

NanoViricides, Inc.

OPKO Health, Inc.

Sarepta Therapeutics, Inc.

VBI Vaccines Inc.

Visterra, Inc.

Zydus Cadila Healthcare Limited

Market segment by Region, regional analysis covers

North America (United States, Canada and Mexico)

Europe (Germany, France, United Kingdom, Russia, Italy, and Rest of Europe)

Asia-Pacific (China, Japan, Korea, India, Southeast Asia, and Australia)

South America (Brazil, Argentina, Colombia, and Rest of South America)

Middle East & Africa (Saudi Arabia, UAE, Egypt, South Africa, and Rest of Middle East & Africa)

The content of the study subjects, includes a total of 14 chapters:

Chapter 1, to describe Influenza A Virus, H3N2 Subtype Infections Drug product scope, market overview, market opportunities, market driving force and market risks.

Chapter 2, to profile the top manufacturers of Influenza A Virus, H3N2 Subtype Infections Drug, with price, sales, revenue and global market share of Influenza A Virus, H3N2 Subtype Infections Drug from 2019 to 2021.

Chapter 3, the Influenza A Virus, H3N2 Subtype Infections Drug competitive situation, sales, revenue and global market share of top manufacturers are analyzed emphatically by landscape contrast.

Chapter 4, the Influenza A Virus, H3N2 Subtype Infections Drug breakdown data are shown at the regional level, to show the sales, revenue and growth by regions, from 2016 to 2026.

Chapter 5 and 6, to segment the sales by type and application, with sales market share and growth rate by type, application, from 2016 to 2026.

Chapter 7, 8, 9, 10 and 11, to break the sales data at the country level, with sales, revenue and market share for key countries in the world, from 2016 to 2021.and Influenza A Virus, H3N2 Subtype Infections Drug market forecast, by regions, type and application, with sales and revenue, from 2021 to 2026.

Chapter 12, 13 and 14, to describe Influenza A Virus, H3N2 Subtype Infections Drug sales channel, distributors, customers, research findings and conclusion, appendix and data source.

Frequently Asked Questions

The base year for the study has been considered 2019, historic year 2014 and 2018, the forecast period considered is from 2020 to 2027. The regions analyzed for the market include North America, Europe, South America, Asia Pacific, and Middle East and Africa. These regions are further analyzed at the country-level. The study also includes attractiveness analysis of type, application and regions which are benchmarked based on their market size, growth rate and attractiveness in terms of present and future opportunity for understanding the future growth of the market.

Market is segmented on the basis:

  • By Type
  • By Application
  • By Region
  • By Country
  • By Manufacturer

The report offers in-depth analysis of driving factors, opportunities, restraints, and challenges for gaining the key insight of the market. The report emphasizes on all the key trends that play a vital role in the enlargement of the market from 2019 to 2026.

The report provides company profile of the key players operating in the market and a comparative analysis based on their business overviews industry offering, segment market share, regional presence, business strategies, innovations, mergers & acquisitions, recent developments, joint venture, collaborations, partnerships, SWOT analysis, and key financial information.

1 Market Overview

1.1 Influenza A Virus, H3N2 Subtype Infections Drug Introduction

1.2 Market Analysis by Type

1.2.1 Overview: Global Influenza A Virus, H3N2 Subtype Infections Drug Revenue by Type: 2019 Versus 2021 Versus 2026

1.2.2 NEO-8877

1.2.3 NP-025

1.2.4 NSC-61610

1.2.5 NVINF-1

1.2.6 Others

1.3 Market Analysis by Application

1.3.1 Overview: Global Influenza A Virus, H3N2 Subtype Infections Drug Revenue by Application: 2019 Versus 2021 Versus 2026

1.3.2 Clinic

1.3.3 Hospital

1.3.4 Others

1.4 Global Influenza A Virus, H3N2 Subtype Infections Drug Market Size & Forecast

1.4.1 Global Influenza A Virus, H3N2 Subtype Infections Drug Sales in Value (2016-2026))

1.4.2 Global Influenza A Virus, H3N2 Subtype Infections Drug Sales in Volume (2016-2026)

1.4.3 Global Influenza A Virus, H3N2 Subtype Infections Drug Price by Type (2016-2026) & (USD/Pcs)

1.5 Global Influenza A Virus, H3N2 Subtype Infections Drug Production Capacity Analysis

1.5.1 Global Influenza A Virus, H3N2 Subtype Infections Drug Total Production Capacity (2016-2026)

1.5.2 Global Influenza A Virus, H3N2 Subtype Infections Drug Production Capacity by Geographic Region

1.6 Market Drivers, Restraints and Trends

1.6.1 Influenza A Virus, H3N2 Subtype Infections Drug Market Drivers

1.6.2 Influenza A Virus, H3N2 Subtype Infections Drug Market Restraints

1.6.3 Influenza A Virus, H3N2 Subtype Infections Drug Trends Analysis

2 Manufacturers Profiles

2.1 AbbVie Inc

2.1.1 AbbVie Inc Details

2.1.2 AbbVie Inc Major Business

2.1.3 AbbVie Inc Influenza A Virus, H3N2 Subtype Infections Drug Product and Services

2.1.4 AbbVie Inc Influenza A Virus, H3N2 Subtype Infections Drug Sales, Price, Revenue, Gross Margin and Market Share (2019-2021)

2.2 AIMM Therapeutics B.V.

2.2.1 AIMM Therapeutics B.V. Details

2.2.2 AIMM Therapeutics B.V. Major Business

2.2.3 AIMM Therapeutics B.V. Influenza A Virus, H3N2 Subtype Infections Drug Product and Services

2.2.4 AIMM Therapeutics B.V. Influenza A Virus, H3N2 Subtype Infections Drug Sales, Price, Revenue, Gross Margin and Market Share (2019-2021)

2.3 Aphios Corporation

2.3.1 Aphios Corporation Details

2.3.2 Aphios Corporation Major Business

2.3.3 Aphios Corporation Influenza A Virus, H3N2 Subtype Infections Drug Product and Services

2.3.4 Aphios Corporation Influenza A Virus, H3N2 Subtype Infections Drug Sales, Price, Revenue, Gross Margin and Market Share (2019-2021)

2.4 Celltrion, Inc.

2.4.1 Celltrion, Inc. Details

2.4.2 Celltrion, Inc. Major Business

2.4.3 Celltrion, Inc. Influenza A Virus, H3N2 Subtype Infections Drug Product and Services

2.4.4 Celltrion, Inc. Influenza A Virus, H3N2 Subtype Infections Drug Sales, Price, Revenue, Gross Margin and Market Share (2019-2021)

2.5 FluGen, Inc.

2.5.1 FluGen, Inc. Details

2.5.2 FluGen, Inc. Major Business

2.5.3 FluGen, Inc. Influenza A Virus, H3N2 Subtype Infections Drug Product and Services

2.5.4 FluGen, Inc. Influenza A Virus, H3N2 Subtype Infections Drug Sales, Price, Revenue, Gross Margin and Market Share (2019-2021)

2.6 Glide Pharmaceutical Technologies Limited

2.6.1 Glide Pharmaceutical Technologies Limited Details

2.6.2 Glide Pharmaceutical Technologies Limited Major Business

2.6.3 Glide Pharmaceutical Technologies Limited Influenza A Virus, H3N2 Subtype Infections Drug Product and Services

2.6.4 Glide Pharmaceutical Technologies Limited Influenza A Virus, H3N2 Subtype Infections Drug Sales, Price, Revenue, Gross Margin and Market Share (2019-2021)

2.7 ILiAD Biotechnologies, LLC

2.7.1 ILiAD Biotechnologies, LLC Details

2.7.2 ILiAD Biotechnologies, LLC Major Business

2.7.3 ILiAD Biotechnologies, LLC Influenza A Virus, H3N2 Subtype Infections Drug Product and Services

2.7.4 ILiAD Biotechnologies, LLC Influenza A Virus, H3N2 Subtype Infections Drug Sales, Price, Revenue, Gross Margin and Market Share (2019-2021)

2.8 Inovio Pharmaceuticals, Inc.

2.8.1 Inovio Pharmaceuticals, Inc. Details

2.8.2 Inovio Pharmaceuticals, Inc. Major Business

2.8.3 Inovio Pharmaceuticals, Inc. Influenza A Virus, H3N2 Subtype Infections Drug Product and Services

2.8.4 Inovio Pharmaceuticals, Inc. Influenza A Virus, H3N2 Subtype Infections Drug Sales, Price, Revenue, Gross Margin and Market Share (2019-2021)

2.9 Johnson & Johnson

2.9.1 Johnson & Johnson Details

2.9.2 Johnson & Johnson Major Business

2.9.3 Johnson & Johnson Influenza A Virus, H3N2 Subtype Infections Drug Product and Services

2.9.4 Johnson & Johnson Influenza A Virus, H3N2 Subtype Infections Drug Sales, Price, Revenue, Gross Margin and Market Share (2019-2021)

2.10 Medicago Inc.

2.10.1 Medicago Inc. Details

2.10.2 Medicago Inc. Major Business

2.10.3 Medicago Inc. Influenza A Virus, H3N2 Subtype Infections Drug Product and Services

2.10.4 Medicago Inc. Influenza A Virus, H3N2 Subtype Infections Drug Sales, Price, Revenue, Gross Margin and Market Share (2019-2021)

2.11 MedImmune, LLC

2.11.1 MedImmune, LLC Details

2.11.2 MedImmune, LLC Major Business

2.11.3 MedImmune, LLC Influenza A Virus, H3N2 Subtype Infections Drug Product and Services

2.11.4 MedImmune, LLC Influenza A Virus, H3N2 Subtype Infections Drug Sales, Price, Revenue, Gross Margin and Market Share (2019-2021)

2.12 Mucosis B.V.

2.12.1 Mucosis B.V. Details

2.12.2 Mucosis B.V. Major Business

2.12.3 Mucosis B.V. Influenza A Virus, H3N2 Subtype Infections Drug Product and Services

2.12.4 Mucosis B.V. Influenza A Virus, H3N2 Subtype Infections Drug Sales, Price, Revenue, Gross Margin and Market Share (2019-2021)

2.13 NanoViricides, Inc.

2.13.1 NanoViricides, Inc. Details

2.13.2 NanoViricides, Inc. Major Business

2.13.3 NanoViricides, Inc. Influenza A Virus, H3N2 Subtype Infections Drug Product and Services

2.13.4 NanoViricides, Inc. Influenza A Virus, H3N2 Subtype Infections Drug Sales, Price, Revenue, Gross Margin and Market Share (2019-2021)

2.14 OPKO Health, Inc.

2.14.1 OPKO Health, Inc. Details

2.14.2 OPKO Health, Inc. Major Business

2.14.3 OPKO Health, Inc. Influenza A Virus, H3N2 Subtype Infections Drug Product and Services

2.14.4 OPKO Health, Inc. Influenza A Virus, H3N2 Subtype Infections Drug Sales, Price, Revenue, Gross Margin and Market Share (2019-2021)

2.15 Sarepta Therapeutics, Inc.

2.15.1 Sarepta Therapeutics, Inc. Details

2.15.2 Sarepta Therapeutics, Inc. Major Business

2.15.3 Sarepta Therapeutics, Inc. Influenza A Virus, H3N2 Subtype Infections Drug Product and Services

2.15.4 Sarepta Therapeutics, Inc. Influenza A Virus, H3N2 Subtype Infections Drug Sales, Price, Revenue, Gross Margin and Market Share (2019-2021)

2.16 VBI Vaccines Inc.

2.16.1 VBI Vaccines Inc. Details

2.16.2 VBI Vaccines Inc. Major Business

2.16.3 VBI Vaccines Inc. Influenza A Virus, H3N2 Subtype Infections Drug Product and Services

2.16.4 VBI Vaccines Inc. Influenza A Virus, H3N2 Subtype Infections Drug Sales, Price, Revenue, Gross Margin and Market Share (2019-2021)

2.17 Visterra, Inc.

2.17.1 Visterra, Inc. Details

2.17.2 Visterra, Inc. Major Business

2.17.3 Visterra, Inc. Influenza A Virus, H3N2 Subtype Infections Drug Product and Services

2.17.4 Visterra, Inc. Influenza A Virus, H3N2 Subtype Infections Drug Sales, Price, Revenue, Gross Margin and Market Share (2019-2021)

2.18 Zydus Cadila Healthcare Limited

2.18.1 Zydus Cadila Healthcare Limited Details

2.18.2 Zydus Cadila Healthcare Limited Major Business

2.18.3 Zydus Cadila Healthcare Limited Influenza A Virus, H3N2 Subtype Infections Drug Product and Services

2.18.4 Zydus Cadila Healthcare Limited Influenza A Virus, H3N2 Subtype Infections Drug Sales, Price, Revenue, Gross Margin and Market Share (2019-2021)

3 Influenza A Virus, H3N2 Subtype Infections Drug Sales by Manufacturer

3.1 Global Influenza A Virus, H3N2 Subtype Infections Drug Sales in Volume by Manufacturer (2019-2021e)

3.2 Global Influenza A Virus, H3N2 Subtype Infections Drug Revenue by Manufacturer (2019-2021e)

3.3 Key Manufacturer Market Position in Influenza A Virus, H3N2 Subtype Infections Drug

3.4 Market Concentration Rate

3.4.1 Top 3 Influenza A Virus, H3N2 Subtype Infections Drug Manufacturer Market Share

3.4.2 Top 6 Influenza A Virus, H3N2 Subtype Infections Drug Manufacturer Market Share

3.5 Global Influenza A Virus, H3N2 Subtype Infections Drug Production Capacity by Company

3.6 Manufacturer by Geography: Head Office and Influenza A Virus, H3N2 Subtype Infections Drug Production Site

3.7 New Entrant and Capacity Expansion Plans

3.8 Mergers & Acquisitions

4 Market Analysis by Region

4.1 Global Influenza A Virus, H3N2 Subtype Infections Drug Market Size by Region

4.1.1 Global Influenza A Virus, H3N2 Subtype Infections Drug Sales in Volume by Region (2016-2026)

4.1.2 Global Influenza A Virus, H3N2 Subtype Infections Drug Revenue by Region (2016-2026)

4.2 North America Influenza A Virus, H3N2 Subtype Infections Drug Revenue (2016-2026)

4.3 Europe Influenza A Virus, H3N2 Subtype Infections Drug Revenue (2016-2026)

4.4 Asia-Pacific Influenza A Virus, H3N2 Subtype Infections Drug Revenue (2016-2026)

4.5 South America Influenza A Virus, H3N2 Subtype Infections Drug Revenue (2016-2026)

4.6 Middle East and Africa Influenza A Virus, H3N2 Subtype Infections Drug Revenue (2016-2026)

5 Market Segment by Type

5.1 Global Influenza A Virus, H3N2 Subtype Infections Drug Sales in Volume by Type (2016-2026)

5.2 Global Influenza A Virus, H3N2 Subtype Infections Drug Revenue by Type (2016-2026)

5.3 Global Influenza A Virus, H3N2 Subtype Infections Drug Price by Type (2016-2026)

6 Market Segment by Application

6.1 Global Influenza A Virus, H3N2 Subtype Infections Drug Sales in Volume by Application (2016-2026)

6.2 Global Influenza A Virus, H3N2 Subtype Infections Drug Revenue by Application (2016-2026)

6.3 Global Influenza A Virus, H3N2 Subtype Infections Drug Price by Application (2016-2026)

7 North America by Country, by Type, and by Application

7.1 North America Influenza A Virus, H3N2 Subtype Infections Drug Sales by Type (2016-2026)

7.2 North America Influenza A Virus, H3N2 Subtype Infections Drug Sales by Application (2016-2026)

7.3 North America Influenza A Virus, H3N2 Subtype Infections Drug Market Size by Country

7.3.1 North America Influenza A Virus, H3N2 Subtype Infections Drug Sales in Volume by Country (2016-2026)

7.3.2 North America Influenza A Virus, H3N2 Subtype Infections Drug Revenue by Country (2016-2026)

7.3.3 United States Market Size and Forecast (2016-2026)

7.3.4 Canada Market Size and Forecast (2016-2026)

7.3.5 Mexico Market Size and Forecast (2016-2026)

8 Europe by Country, by Type, and by Application

8.1 Europe Influenza A Virus, H3N2 Subtype Infections Drug Sales by Type (2016-2026)

8.2 Europe Influenza A Virus, H3N2 Subtype Infections Drug Sales by Application (2016-2026)

8.3 Europe Influenza A Virus, H3N2 Subtype Infections Drug Market Size by Country

8.3.1 Europe Influenza A Virus, H3N2 Subtype Infections Drug Sales in Volume by Country (2016-2026)

8.3.2 Europe Influenza A Virus, H3N2 Subtype Infections Drug Revenue by Country (2016-2026)

8.3.3 Germany Market Size and Forecast (2016-2026)

8.3.4 France Market Size and Forecast (2016-2026)

8.3.5 United Kingdom Market Size and Forecast (2016-2026)

8.3.6 Russia Market Size and Forecast (2016-2026)

8.3.7 Italy Market Size and Forecast (2016-2026)

9 Asia-Pacific by Country, by Type, and by Application

9.1 Asia-Pacific Influenza A Virus, H3N2 Subtype Infections Drug Sales by Type (2016-2026)

9.2 Asia-Pacific Influenza A Virus, H3N2 Subtype Infections Drug Sales by Application (2016-2026)

9.3 Asia-Pacific Influenza A Virus, H3N2 Subtype Infections Drug Market Size by Region

9.3.1 Asia-Pacific Influenza A Virus, H3N2 Subtype Infections Drug Sales in Volume by Region (2016-2026)

9.3.2 Asia-Pacific Influenza A Virus, H3N2 Subtype Infections Drug Revenue by Region (2016-2026)

9.3.3 China Market Size and Forecast (2016-2026)

9.3.4 Japan Market Size and Forecast (2016-2026)

9.3.5 Korea Market Size and Forecast (2016-2026)

9.3.6 India Market Size and Forecast (2016-2026)

9.3.7 Southeast Asia Market Size and Forecast (2016-2026)

9.3.8 Australia Market Size and Forecast (2016-2026)

10 South America by Country, by Type, and by Application

10.1 South America Influenza A Virus, H3N2 Subtype Infections Drug Sales by Type (2016-2026)

10.2 South America Influenza A Virus, H3N2 Subtype Infections Drug Sales by Application (2016-2026)

10.3 South America Influenza A Virus, H3N2 Subtype Infections Drug Market Size by Country

10.3.1 South America Influenza A Virus, H3N2 Subtype Infections Drug Sales in Volume by Country (2016-2026)

10.3.2 South America Influenza A Virus, H3N2 Subtype Infections Drug Revenue by Country (2016-2026)

10.3.3 Brazil Market Size and Forecast (2016-2026)

10.3.4 Argentina Market Size and Forecast (2016-2026)

11 Middle East & Africa by Country, by Type, and by Application

11.1 Middle East & Africa Influenza A Virus, H3N2 Subtype Infections Drug Sales by Type (2016-2026)

11.2 Middle East & Africa Influenza A Virus, H3N2 Subtype Infections Drug Sales by Application (2016-2026)

11.3 Middle East & Africa Influenza A Virus, H3N2 Subtype Infections Drug Market Size by Country

11.3.1 Middle East & Africa Influenza A Virus, H3N2 Subtype Infections Drug Sales in Volume by Country (2016-2026)

11.3.2 Middle East & Africa Influenza A Virus, H3N2 Subtype Infections Drug Revenue by Country (2016-2026)

11.3.3 Turkey Market Size and Forecast (2016-2026)

11.3.4 Egypt Market Size and Forecast (2016-2026)

11.3.5 Saudi Arabia Market Size and Forecast (2016-2026)

11.3.6 South Africa Market Size and Forecast (2016-2026)

12 Sales Channel, Distributors, Traders and Dealers

12.1 Sales Channel

12.1.1 Direct Marketing

12.1.2 Indirect Marketing

12.2 Influenza A Virus, H3N2 Subtype Infections Drug Typical Distributors

12.3 Influenza A Virus, H3N2 Subtype Infections Drug Typical Customers

13 Research Findings and Conclusion

14 Appendix

14.1 Methodology

14.2 Research Process and Data Source

14.3 Disclaimer

List of Tables

Table 1. Global Influenza A Virus, H3N2 Subtype Infections Drug Revenue by Type, (USD Million), 2021-2026

Table 2. Global Influenza A Virus, H3N2 Subtype Infections Drug Revenue by Application, (USD Million), 2021-2026

Table 3. AbbVie Inc Basic Information, Manufacturing Base and Competitors

Table 4. AbbVie Inc Major Business

Table 5. AbbVie Inc Influenza A Virus, H3N2 Subtype Infections Drug Product and Services

Table 6. AbbVie Inc Influenza A Virus, H3N2 Subtype Infections Drug Sales (K Pcs), Price (USD/Pcs), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)

Table 7. AIMM Therapeutics B.V. Basic Information, Manufacturing Base and Competitors

Table 8. AIMM Therapeutics B.V. Major Business

Table 9. AIMM Therapeutics B.V. Influenza A Virus, H3N2 Subtype Infections Drug Product and Services

Table 10. AIMM Therapeutics B.V. Influenza A Virus, H3N2 Subtype Infections Drug Sales (K Pcs), Price (USD/Pcs), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)

Table 11. Aphios Corporation Basic Information, Manufacturing Base and Competitors

Table 12. Aphios Corporation Major Business

Table 13. Aphios Corporation Influenza A Virus, H3N2 Subtype Infections Drug Product and Services

Table 14. Aphios Corporation Influenza A Virus, H3N2 Subtype Infections Drug Sales (K Pcs), Price (USD/Pcs), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)

Table 15. Celltrion, Inc. Basic Information, Manufacturing Base and Competitors

Table 16. Celltrion, Inc. Major Business

Table 17. Celltrion, Inc. Influenza A Virus, H3N2 Subtype Infections Drug Product and Services

Table 18. Celltrion, Inc. Influenza A Virus, H3N2 Subtype Infections Drug Sales (K Pcs), Price (USD/Pcs), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)

Table 19. FluGen, Inc. Basic Information, Manufacturing Base and Competitors

Table 20. FluGen, Inc. Major Business

Table 21. FluGen, Inc. Influenza A Virus, H3N2 Subtype Infections Drug Product and Services

Table 22. FluGen, Inc. Influenza A Virus, H3N2 Subtype Infections Drug Sales (K Pcs), Price (USD/Pcs), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)

Table 23. Glide Pharmaceutical Technologies Limited Basic Information, Manufacturing Base and Competitors

Table 24. Glide Pharmaceutical Technologies Limited Major Business

Table 25. Glide Pharmaceutical Technologies Limited Influenza A Virus, H3N2 Subtype Infections Drug Product and Services

Table 26. Glide Pharmaceutical Technologies Limited Influenza A Virus, H3N2 Subtype Infections Drug Sales (K Pcs), Price (USD/Pcs), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)

Table 27. ILiAD Biotechnologies, LLC Basic Information, Manufacturing Base and Competitors

Table 28. ILiAD Biotechnologies, LLC Major Business

Table 29. ILiAD Biotechnologies, LLC Influenza A Virus, H3N2 Subtype Infections Drug Product and Services

Table 30. ILiAD Biotechnologies, LLC Influenza A Virus, H3N2 Subtype Infections Drug Sales (K Pcs), Price (USD/Pcs), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)

Table 31. Inovio Pharmaceuticals, Inc. Basic Information, Manufacturing Base and Competitors

Table 32. Inovio Pharmaceuticals, Inc. Major Business

Table 33. Inovio Pharmaceuticals, Inc. Influenza A Virus, H3N2 Subtype Infections Drug Product and Services

Table 34. Inovio Pharmaceuticals, Inc. Influenza A Virus, H3N2 Subtype Infections Drug Sales (K Pcs), Price (USD/Pcs), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)

Table 35. Johnson & Johnson Basic Information, Manufacturing Base and Competitors

Table 36. Johnson & Johnson Major Business

Table 37. Johnson & Johnson Influenza A Virus, H3N2 Subtype Infections Drug Product and Services

Table 38. Johnson & Johnson Influenza A Virus, H3N2 Subtype Infections Drug Sales (K Pcs), Price (USD/Pcs), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)

Table 39. Medicago Inc. Basic Information, Manufacturing Base and Competitors

Table 40. Medicago Inc. Major Business

Table 41. Medicago Inc. Influenza A Virus, H3N2 Subtype Infections Drug Product and Services

Table 42. Medicago Inc. Influenza A Virus, H3N2 Subtype Infections Drug Sales (K Pcs), Price (USD/Pcs), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)

Table 43. MedImmune, LLC Basic Information, Manufacturing Base and Competitors

Table 44. MedImmune, LLC Major Business

Table 45. MedImmune, LLC Influenza A Virus, H3N2 Subtype Infections Drug Product and Services

Table 46. MedImmune, LLC Influenza A Virus, H3N2 Subtype Infections Drug Sales (K Pcs), Price (USD/Pcs), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)

Table 47. Mucosis B.V. Basic Information, Manufacturing Base and Competitors

Table 48. Mucosis B.V. Major Business

Table 49. Mucosis B.V. Influenza A Virus, H3N2 Subtype Infections Drug Product and Services

Table 50. Mucosis B.V. Influenza A Virus, H3N2 Subtype Infections Drug Sales (K Pcs), Price (USD/Pcs), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)

Table 51. NanoViricides, Inc. Basic Information, Manufacturing Base and Competitors

Table 52. NanoViricides, Inc. Major Business

Table 53. NanoViricides, Inc. Influenza A Virus, H3N2 Subtype Infections Drug Product and Services

Table 54. NanoViricides, Inc. Influenza A Virus, H3N2 Subtype Infections Drug Sales (K Pcs), Price (USD/Pcs), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)

Table 55. OPKO Health, Inc. Basic Information, Manufacturing Base and Competitors

Table 56. OPKO Health, Inc. Major Business

Table 57. OPKO Health, Inc. Influenza A Virus, H3N2 Subtype Infections Drug Product and Services

Table 58. OPKO Health, Inc. Influenza A Virus, H3N2 Subtype Infections Drug Sales (K Pcs), Price (USD/Pcs), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)

Table 59. Sarepta Therapeutics, Inc. Basic Information, Manufacturing Base and Competitors

Table 60. Sarepta Therapeutics, Inc. Major Business

Table 61. Sarepta Therapeutics, Inc. Influenza A Virus, H3N2 Subtype Infections Drug Product and Services

Table 62. Sarepta Therapeutics, Inc. Influenza A Virus, H3N2 Subtype Infections Drug Sales (K Pcs), Price (USD/Pcs), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)

Table 63. VBI Vaccines Inc. Basic Information, Manufacturing Base and Competitors

Table 64. VBI Vaccines Inc. Major Business

Table 65. VBI Vaccines Inc. Influenza A Virus, H3N2 Subtype Infections Drug Product and Services

Table 66. VBI Vaccines Inc. Influenza A Virus, H3N2 Subtype Infections Drug Sales (K Pcs), Price (USD/Pcs), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)

Table 67. Visterra, Inc. Basic Information, Manufacturing Base and Competitors

Table 68. Visterra, Inc. Major Business

Table 69. Visterra, Inc. Influenza A Virus, H3N2 Subtype Infections Drug Product and Services

Table 70. Visterra, Inc. Influenza A Virus, H3N2 Subtype Infections Drug Sales (K Pcs), Price (USD/Pcs), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)

Table 71. Zydus Cadila Healthcare Limited Basic Information, Manufacturing Base and Competitors

Table 72. Zydus Cadila Healthcare Limited Major Business

Table 73. Zydus Cadila Healthcare Limited Influenza A Virus, H3N2 Subtype Infections Drug Product and Services

Table 74. Zydus Cadila Healthcare Limited Influenza A Virus, H3N2 Subtype Infections Drug Sales (K Pcs), Price (USD/Pcs), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)

Table 75. Global Influenza A Virus, H3N2 Subtype Infections Drug Sales by Manufacturer (2019-2021e) & (K Pcs)

Table 76. Global Influenza A Virus, H3N2 Subtype Infections Drug Revenue by Manufacturer (2019-2021e) & (USD Million)

Table 77. Market Position of Manufacturers in Influenza A Virus, H3N2 Subtype Infections Drug, (Tier 1, Tier 2, and Tier 3), Based on Revenue in 2020

Table 78. Global Influenza A Virus, H3N2 Subtype Infections Drug Production Capacity by Company, (K Pcs): 2020 VS 2021

Table 79. Head Office and Influenza A Virus, H3N2 Subtype Infections Drug Production Site of Key Manufacturer

Table 80. Influenza A Virus, H3N2 Subtype Infections Drug New Entrant and Capacity Expansion Plans

Table 81. Influenza A Virus, H3N2 Subtype Infections Drug Mergers & Acquisitions in the Past Five Years

Table 82. Global Influenza A Virus, H3N2 Subtype Infections Drug Sales by Region (2016-2021e) & (K Pcs)

Table 83. Global Influenza A Virus, H3N2 Subtype Infections Drug Sales by Region (2021-2026) & (K Pcs)

Table 84. Global Influenza A Virus, H3N2 Subtype Infections Drug Revenue by Region (2016-2021e) & (USD Million)

Table 85. Global Influenza A Virus, H3N2 Subtype Infections Drug Revenue by Region (2021-2026) & (USD Million)

Table 86. Global Influenza A Virus, H3N2 Subtype Infections Drug Sales by Type (2016-2021e) & (K Pcs)

Table 87. Global Influenza A Virus, H3N2 Subtype Infections Drug Sales by Type (2021-2026) & (K Pcs)

Table 88. Global Influenza A Virus, H3N2 Subtype Infections Drug Revenue by Type (2016-2021e) & (USD Million)

Table 89. Global Influenza A Virus, H3N2 Subtype Infections Drug Revenue by Type (2021-2026) & (USD Million)

Table 90. Global Influenza A Virus, H3N2 Subtype Infections Drug Price by Type (2016-2021e) & (USD/Pcs)

Table 91. Global Influenza A Virus, H3N2 Subtype Infections Drug Price by Type (2021-2026) & (USD/Pcs)

Table 92. Global Influenza A Virus, H3N2 Subtype Infections Drug Sales by Application (2016-2021e) & (K Pcs)

Table 93. Global Influenza A Virus, H3N2 Subtype Infections Drug Sales by Application (2021-2026) & (K Pcs)

Table 94. Global Influenza A Virus, H3N2 Subtype Infections Drug Revenue by Application (2016-2021e) & (USD Million)

Table 95. Global Influenza A Virus, H3N2 Subtype Infections Drug Revenue by Application (2021-2026) & (USD Million)

Table 96. Global Influenza A Virus, H3N2 Subtype Infections Drug Price by Application (2016-2021e) & (USD/Pcs)

Table 97. Global Influenza A Virus, H3N2 Subtype Infections Drug Price by Application (2021-2026) & (USD/Pcs)

Table 98. North America Influenza A Virus, H3N2 Subtype Infections Drug Sales by Country (2016-2021e) & (K Pcs)

Table 99. North America Influenza A Virus, H3N2 Subtype Infections Drug Sales by Country (2021-2026) & (K Pcs)

Table 100. North America Influenza A Virus, H3N2 Subtype Infections Drug Revenue by Country (2016-2021e) & (USD Million)

Table 101. North America Influenza A Virus, H3N2 Subtype Infections Drug Revenue by Country (2021-2026) & (USD Million)

Table 102. North America Influenza A Virus, H3N2 Subtype Infections Drug Sales by Type (2016-2021e) & (K Pcs)

Table 103. North America Influenza A Virus, H3N2 Subtype Infections Drug Sales by Type (2021-2026) & (K Pcs)

Table 104. North America Influenza A Virus, H3N2 Subtype Infections Drug Sales by Application (2016-2021e) & (K Pcs)

Table 105. North America Influenza A Virus, H3N2 Subtype Infections Drug Sales by Application (2021-2026) & (K Pcs)

Table 106. Europe Influenza A Virus, H3N2 Subtype Infections Drug Sales by Country (2016-2021e) & (K Pcs)

Table 107. Europe Influenza A Virus, H3N2 Subtype Infections Drug Sales by Country (2021-2026) & (K Pcs)

Table 108. Europe Influenza A Virus, H3N2 Subtype Infections Drug Revenue by Country (2016-2021e) & (USD Million)

Table 109. Europe Influenza A Virus, H3N2 Subtype Infections Drug Revenue by Country (2021-2026) & (USD Million)

Table 110. Europe Influenza A Virus, H3N2 Subtype Infections Drug Sales by Type (2016-2021e) & (K Pcs)

Table 111. Europe Influenza A Virus, H3N2 Subtype Infections Drug Sales by Type (2021-2026) & (K Pcs)

Table 112. Europe Influenza A Virus, H3N2 Subtype Infections Drug Sales by Application (2016-2021e) & (K Pcs)

Table 113. Europe Influenza A Virus, H3N2 Subtype Infections Drug Sales by Application (2021-2026) & (K Pcs)

Table 114. Asia-Pacific Influenza A Virus, H3N2 Subtype Infections Drug Sales by Region (2016-2021e) & (K Pcs)

Table 115. Asia-Pacific Influenza A Virus, H3N2 Subtype Infections Drug Sales by Region (2021-2026) & (K Pcs)

Table 116. Asia-Pacific Influenza A Virus, H3N2 Subtype Infections Drug Revenue by Region (2016-2021e) & (USD Million)

Table 117. Asia-Pacific Influenza A Virus, H3N2 Subtype Infections Drug Revenue by Region (2021-2026) & (USD Million)

Table 118. Asia-Pacific Influenza A Virus, H3N2 Subtype Infections Drug Sales by Type (2016-2021e) & (K Pcs)

Table 119. Asia-Pacific Influenza A Virus, H3N2 Subtype Infections Drug Sales by Type (2021-2026) & (K Pcs)

Table 120. Asia-Pacific Influenza A Virus, H3N2 Subtype Infections Drug Sales by Application (2016-2021e) & (K Pcs)

Table 121. Asia-Pacific Influenza A Virus, H3N2 Subtype Infections Drug Sales by Application (2021-2026) & (K Pcs)

Table 122. South America Influenza A Virus, H3N2 Subtype Infections Drug Sales by Country (2016-2021e) & (K Pcs)

Table 123. South America Influenza A Virus, H3N2 Subtype Infections Drug Sales by Country (2021-2026) & (K Pcs)

Table 124. South America Influenza A Virus, H3N2 Subtype Infections Drug Revenue by Country (2016-2021e) & (USD Million)

Table 125. South America Influenza A Virus, H3N2 Subtype Infections Drug Revenue by Country (2021-2026) & (USD Million)

Table 126. South America Influenza A Virus, H3N2 Subtype Infections Drug Sales by Type (2016-2021e) & (K Pcs)

Table 127. South America Influenza A Virus, H3N2 Subtype Infections Drug Sales by Type (2021-2026) & (K Pcs)

Table 128. South America Influenza A Virus, H3N2 Subtype Infections Drug Sales by Application (2016-2021e) & (K Pcs)

Table 129. South America Influenza A Virus, H3N2 Subtype Infections Drug Sales by Application (2021-2026) & (K Pcs)

Table 130. Middle East & Africa Influenza A Virus, H3N2 Subtype Infections Drug Sales by Country (2016-2021e) & (K Pcs)

Table 131. Middle East & Africa Influenza A Virus, H3N2 Subtype Infections Drug Sales by Country (2021-2026) & (K Pcs)

Table 132. Middle East & Africa Influenza A Virus, H3N2 Subtype Infections Drug Revenue by Country (2016-2021e) & (USD Million)

Table 133. Middle East & Africa Influenza A Virus, H3N2 Subtype Infections Drug Revenue by Country (2021-2026) & (USD Million)

Table 134. Middle East & Africa Influenza A Virus, H3N2 Subtype Infections Drug Sales by Type (2016-2021e) & (K Pcs)

Table 135. Middle East & Africa Influenza A Virus, H3N2 Subtype Infections Drug Sales by Type (2021-2026) & (K Pcs)

Table 136. Middle East & Africa Influenza A Virus, H3N2 Subtype Infections Drug Sales by Application (2016-2021e) & (K Pcs)

Table 137. Middle East & Africa Influenza A Virus, H3N2 Subtype Infections Drug Sales by Application (2021-2026) & (K Pcs)

Table 138. Direct Channel Pros & Cons

Table 139. Indirect Channel Pros & Cons

Table 140. Influenza A Virus, H3N2 Subtype Infections Drug Typical Distributors

Table 141. Influenza A Virus, H3N2 Subtype Infections Drug Typical Customers

List of Figures

Figure 1. Influenza A Virus, H3N2 Subtype Infections Drug Picture

Figure 2. Global Influenza A Virus, H3N2 Subtype Infections Drug Sales Market Share by Type in 2020

Figure 3. NEO-8877

Figure 4. NP-025

Figure 5. NSC-61610

Figure 6. NVINF-1

Figure 7. Others

Figure 8. Global Influenza A Virus, H3N2 Subtype Infections Drug Sales Market Share by Application in 2020

Figure 9. Clinic

Figure 10. Hospital

Figure 11. Others

Figure 12. Global Influenza A Virus, H3N2 Subtype Infections Drug Market Size, (USD Million) & (K Pcs): 2020 VS 2021 VS 2026

Figure 13. Global Influenza A Virus, H3N2 Subtype Infections Drug Market Size and Forecast (2016-2026) & (USD Million)

Figure 14. Global Influenza A Virus, H3N2 Subtype Infections Drug Sales (2016-2026) & (K Pcs)

Figure 15. Global Influenza A Virus, H3N2 Subtype Infections Drug Price by Type (2016-2026) & (USD/Pcs)

Figure 16. Global Influenza A Virus, H3N2 Subtype Infections Drug Production Capacity (2016-2026) & (K Pcs)

Figure 17. Global Influenza A Virus, H3N2 Subtype Infections Drug Production Capacity by Geographic Region: 2020 VS 2021

Figure 18. Influenza A Virus, H3N2 Subtype Infections Drug Market Drivers

Figure 19. Influenza A Virus, H3N2 Subtype Infections Drug Market Restraints

Figure 20. Influenza A Virus, H3N2 Subtype Infections Drug Market Trends

Figure 21. Global Influenza A Virus, H3N2 Subtype Infections Drug Sales Market Share by Manufacturer in 2020

Figure 22. Global Influenza A Virus, H3N2 Subtype Infections Drug Revenue Market Share by Manufacturer in 2020

Figure 23. Influenza A Virus, H3N2 Subtype Infections Drug Market Share by Company Type (Tier 1, Tier 2, and Tier 3)

Figure 24. Top 3 Influenza A Virus, H3N2 Subtype Infections Drug Manufacturer (Revenue) Market Share in 2020

Figure 25. Top 6 Influenza A Virus, H3N2 Subtype Infections Drug Manufacturer (Revenue) Market Share in 2020

Figure 26. Global Influenza A Virus, H3N2 Subtype Infections Drug Sales Market Share by Region (2016-2026)

Figure 27. Global Influenza A Virus, H3N2 Subtype Infections Drug Revenue Market Share by Region (2016-2026)

Figure 28. North America Influenza A Virus, H3N2 Subtype Infections Drug Revenue (2016-2026) & (USD Million)

Figure 29. Europe Influenza A Virus, H3N2 Subtype Infections Drug Revenue (2016-2026) & (USD Million)

Figure 30. Asia-Pacific Influenza A Virus, H3N2 Subtype Infections Drug Revenue (2016-2026) & (USD Million)

Figure 31. South America Influenza A Virus, H3N2 Subtype Infections Drug Revenue (2016-2026) & (USD Million)

Figure 32. Middle East & Africa Influenza A Virus, H3N2 Subtype Infections Drug Revenue (2016-2026) & (USD Million)

Figure 33. Global Influenza A Virus, H3N2 Subtype Infections Drug Sales Market Share by Type (2016-2026)

Figure 34. Global Influenza A Virus, H3N2 Subtype Infections Drug Revenue Market Share by Type (2016-2026)

Figure 35. Global Influenza A Virus, H3N2 Subtype Infections Drug Price by Type (2016-2026) & (USD/Pcs)

Figure 36. Global Influenza A Virus, H3N2 Subtype Infections Drug Sales Market Share by Application (2016-2026)

Figure 37. Global Influenza A Virus, H3N2 Subtype Infections Drug Revenue Market Share by Application (2016-2026)

Figure 38. Global Influenza A Virus, H3N2 Subtype Infections Drug Price by Application (2016-2026) & (USD/Pcs)

Figure 39. North America Influenza A Virus, H3N2 Subtype Infections Drug Sales Market Share by Type (2016-2026)

Figure 40. North America Influenza A Virus, H3N2 Subtype Infections Drug Sales Market Share by Application (2016-2026)

Figure 41. North America Influenza A Virus, H3N2 Subtype Infections Drug Sales Market Share by Country (2016-2026)

Figure 42. North America Influenza A Virus, H3N2 Subtype Infections Drug Revenue Market Share by Country (2016-2026)

Figure 43. United States Influenza A Virus, H3N2 Subtype Infections Drug Revenue and Growth Rate (2016-2026) & (USD Million)

Figure 44. Canada Influenza A Virus, H3N2 Subtype Infections Drug Revenue and Growth Rate (2016-2026) & (USD Million)

Figure 45. Mexico Influenza A Virus, H3N2 Subtype Infections Drug Revenue and Growth Rate (2016-2026) & (USD Million)

Figure 46. Europe Influenza A Virus, H3N2 Subtype Infections Drug Sales Market Share by Type (2016-2026)

Figure 47. Europe Influenza A Virus, H3N2 Subtype Infections Drug Sales Market Share by Application (2016-2026)

Figure 48. Europe Influenza A Virus, H3N2 Subtype Infections Drug Sales Market Share by Country (2016-2026)

Figure 49. Europe Influenza A Virus, H3N2 Subtype Infections Drug Revenue Market Share by Country (2016-2026)

Figure 50. Germany Influenza A Virus, H3N2 Subtype Infections Drug Revenue and Growth Rate (2016-2026) & (USD Million)

Figure 51. France Influenza A Virus, H3N2 Subtype Infections Drug Revenue and Growth Rate (2016-2026) & (USD Million)

Figure 52. United Kingdom Influenza A Virus, H3N2 Subtype Infections Drug Revenue and Growth Rate (2016-2026) & (USD Million)

Figure 53. Russia Influenza A Virus, H3N2 Subtype Infections Drug Revenue and Growth Rate (2016-2026) & (USD Million)

Figure 54. Italy Influenza A Virus, H3N2 Subtype Infections Drug Revenue and Growth Rate (2016-2026) & (USD Million)

Figure 55. Asia-Pacific Influenza A Virus, H3N2 Subtype Infections Drug Sales Market Share by Region (2016-2026)

Figure 56. Asia-Pacific Influenza A Virus, H3N2 Subtype Infections Drug Sales Market Share by Application (2016-2026)

Figure 57. Asia-Pacific Influenza A Virus, H3N2 Subtype Infections Drug Sales Market Share by Region (2016-2026)

Figure 58. Asia-Pacific Influenza A Virus, H3N2 Subtype Infections Drug Revenue Market Share by Region (2016-2026)

Figure 59. China Influenza A Virus, H3N2 Subtype Infections Drug Revenue and Growth Rate (2016-2026) & (USD Million)

Figure 60. Japan Influenza A Virus, H3N2 Subtype Infections Drug Revenue and Growth Rate (2016-2026) & (USD Million)

Figure 61. Korea Influenza A Virus, H3N2 Subtype Infections Drug Revenue and Growth Rate (2016-2026) & (USD Million)

Figure 62. India Influenza A Virus, H3N2 Subtype Infections Drug Revenue and Growth Rate (2016-2026) & (USD Million)

Figure 63. Southeast Asia Influenza A Virus, H3N2 Subtype Infections Drug Revenue and Growth Rate (2016-2026) & (USD Million)

Figure 64. Australia Influenza A Virus, H3N2 Subtype Infections Drug Revenue and Growth Rate (2016-2026) & (USD Million)

Figure 65. South America Influenza A Virus, H3N2 Subtype Infections Drug Sales Market Share by Type (2016-2026)

Figure 66. South America Influenza A Virus, H3N2 Subtype Infections Drug Sales Market Share by Application (2016-2026)

Figure 67. South America Influenza A Virus, H3N2 Subtype Infections Drug Sales Market Share by Country (2016-2026)

Figure 68. South America Influenza A Virus, H3N2 Subtype Infections Drug Revenue Market Share by Country (2016-2026)

Figure 69. Brazil Influenza A Virus, H3N2 Subtype Infections Drug Revenue and Growth Rate (2016-2026) & (USD Million)

Figure 70. Argentina Influenza A Virus, H3N2 Subtype Infections Drug Revenue and Growth Rate (2016-2026) & (USD Million)

Figure 71. Middle East & Africa Influenza A Virus, H3N2 Subtype Infections Drug Sales Market Share by Type (2016-2026)

Figure 72. Middle East & Africa Influenza A Virus, H3N2 Subtype Infections Drug Sales Market Share by Application (2016-2026)

Figure 73. Middle East & Africa Influenza A Virus, H3N2 Subtype Infections Drug Sales Market Share by Country (2016-2026)

Figure 74. Middle East & Africa Influenza A Virus, H3N2 Subtype Infections Drug Revenue Market Share by Country (2016-2026)

Figure 75. Turkey Influenza A Virus, H3N2 Subtype Infections Drug Revenue and Growth Rate (2016-2026) & (USD Million)

Figure 76. Egypt Influenza A Virus, H3N2 Subtype Infections Drug Revenue and Growth Rate (2016-2026) & (USD Million)

Figure 77. Saudi Arabia Influenza A Virus, H3N2 Subtype Infections Drug Revenue and Growth Rate (2016-2026) & (USD Million)

Figure 78. South Africa Influenza A Virus, H3N2 Subtype Infections Drug Revenue and Growth Rate (2016-2026) & (USD Million)

Figure 79. Sales Channel: Direct Channel vs Indirect Channel

Figure 80. Methodology

Figure 81. Research Process and Data Source